TNF and myeloid sarcoma: In people with MS, there is an imbalance between Th1/Th17 and T regulatory subset, resulting in increased Th1 pro-inflammatory cytokines such as interleukin-1 (IL-1), IL-6, and tumor necrosis factor (TNF-α).